In fact, semaglutide is 94% similar to the GLP-1 that our body produces
The production of NO by activating iNOS is initiated by signals from proinflammatory cytokines, including interleukin (IL)-1, IL-17, tumour necrosis factor- and interferon- (Nathan and Xie, 1994)
The best outcomes happen when medication is paired with structured lifestyle support
Pongkan W, Jinawong K, Pratchayasakul W, Jaiwongkam T, Kerdphoo S, Tokuda M, Chattipakorn SC, Chattipakorn N (2021) D-allulose provides cardioprotective effect by attenuating cardiac mitochondrial dysfunction in obesity-induced insulin-resistant rats
However, the temporal reduction of MACE events in people with type 2 diabetes treated with GLP-1RA takes longer, becoming evident from 12 to 18 months from trial initiation [115, 116]
Healthcare providers carefully screen patients before initiating treatment to ensure their safety and optimize outcomes